Skip to content
  • + 33 (0) 1 55 26 82 16
  • contact@cardiawave.com
  • 3-5 rue Jules Guesde, Bat B, 92300 Levallois-Perret, France
  • + 33 (0) 1 55 26 82 16
  • contact@cardiawave.com
  • 3-5 rue Jules Guesde, Bat B, 92300 Levallois-Perret, France

Search

  • Home
  • About Us
    • Cardiawave
    • Mission and values
    • The Team
    • Careers
  • Aortic Stenosis
    • Unmet Medical Need
    • Current Treatment
  • Health Professionals
    • Our device: Valvosoft® 
    • Scientific Publications
    • Congresses
  • News
    • News
    • Press releases
  • Contact
About Us

🔊 New Interview – Inside Cardiawave’s Journey with the EIC Scaling Club🎙️ Cardiawave’s presentation at LSI 2025

Jan 13, 2026 HeleneCardiawave 0
Events

Cardiawave at JESFC 2026!

Jan 8, 2026 HeleneCardiawave 0
Press Release

VALVOSOFT®, the first non-invasive treatment for severe Symptomatic Aortic Stenosis (sSAS) from Cardiawave receives CE Marking

Dec 4, 2025 HeleneCardiawave 0
Press Release

VALVOSOFT®, le premier traitement non invasif de la Sténose Aortique Sévère symptomatique (sSAS) développé par Cardiawave, obtient le marquage CE

Dec 4, 2025 HeleneCardiawave 0
Events

📢 Cardiawave’s Valvosoft® to be presented at PCR London Valves 2025!

Nov 6, 2025 HeleneCardiawave 0
Press Release

Cardiawave renforce son leadership avec la nomination de Jonathan Freeman, Président du CA

Oct 30, 2025 HeleneCardiawave 0

Blog

420x300-others2
Other news

PLAN DEEPTECH

Mar 18, 2021
READ MORE
420x300-aortic1
Aortic Stenosis

ANIMATION OF OUR DISRUPTIVE AND PATENTED TECHNOLOGY

Mar 16, 2021
READ MORE
420x300-they-talk1
About Us

CARDIAWAVE’S FIRST-IN-HUMAN TRIAL – FUS FOUNDATION

Mar 11, 2021
READ MORE
650x450-news-bleu
Events

MEDTECH INNOVATOR VIRTUAL PITCH EVENT

Mar 8, 2021
READ MORE
420x300-they-talk2
About Us

PREMIERS RESULTATS D’UN TRAITEMENT NON-INVASIF – AP-HP

Feb 4, 2021
READ MORE
420x300-internal2
Corporate News

AMEL KORSO-FECIANE, TEST BENCH ENGINEER

Feb 2, 2021
READ MORE
420x300-others3
Other news

1,500 FOLLOWERS ON LINKEDIN

Jan 19, 2021
READ MORE
420x300-others4
Other news

HAPPY NEW YEAR!

Dec 31, 2020
READ MORE
650x450-press-release2
Press Release

Cardiawave has been granted authorization by the ANSM

Nov 17, 2020

The French MedTech Cardiawave has been granted authorization by the Agence Nationale de Sécurité

READ MORE
650x450-press-release1
Press Release

Cardiawave has secured 8 million euros in funding

Sep 1, 2020

The French start-up Cardiawave has developed a highly innovative and non-invasive medical device

READ MORE

Posts pagination

PrevPrevious page Page 1 … Page 19 Page 20 Page 21 NextNext page

Categories

  • About Us
  • Aortic Stenosis
  • Careers
  • Clinical Studies
  • Corporate News
  • Events
  • Other news
  • Press Release
  • Scientific Publications

Featured Posts

About Us

🔊 New Interview – Inside Cardiawave’s Journey with the EIC Scaling Club🎙️ Cardiawave’s presentation at LSI 2025

Jan 13, 2026 HeleneCardiawave 0
Events

Cardiawave at JESFC 2026!

Jan 8, 2026 HeleneCardiawave 0
Press Release

VALVOSOFT®, the first non-invasive treatment for severe Symptomatic Aortic Stenosis (sSAS) from Cardiawave receives CE Marking

Dec 4, 2025 HeleneCardiawave 0
Press Release

VALVOSOFT®, le premier traitement non invasif de la Sténose Aortique Sévère symptomatique (sSAS) développé par Cardiawave, obtient le marquage CE

Dec 4, 2025 HeleneCardiawave 0
Events

📢 Cardiawave’s Valvosoft® to be presented at PCR London Valves 2025!

Nov 6, 2025 HeleneCardiawave 0
Press Release

Cardiawave renforce son leadership avec la nomination de Jonathan Freeman, Président du CA

Oct 30, 2025 HeleneCardiawave 0

l Latest news

  • 🔊 New Interview – Inside Cardiawave’s Journey with the EIC Scaling Club🎙️ Cardiawave’s presentation at LSI 2025
  • Cardiawave at JESFC 2026!

l Our social networks

  • LinkedIn
  • Twitter

l Contact Us

3-5 rue Jules Guesde, Bat B, 92300 Levallois-Perret, France
+ 33 (0) 1 55 26 82 16
contact@cardiawave.com

Copyright © Cardiawave l February 5th 2026
  • Legal Mentions